ADVERTISEMENT

404

Not Found

Is this what you were looking for?

tag industry drug development careers policy publishing

How Orphan Drugs Became a Highly Profitable Industry
Diana Kwon | May 1, 2018 | 10+ min read
Government incentives, advances in technology, and an army of patient advocates have spun a successful market—but abuses of the system and exorbitant prices could cause a backlash.
A bat flying in a dark cave
Turning on the Bat Signal
Hannah Thomasy, PhD | Mar 15, 2024 | 10+ min read
Scientists around the world investigate how bat immune systems cope with viral attacks and how this information could be used to keep humans safe.
Q&A: From FDA to Industry
Kerry Grens | Sep 27, 2016 | 5 min read
Among a subset of US Food and Drug Administration regulators who leave the agency, more than half go to work for pharmaceutical companies, researchers report.
Top Breast Cancer Researcher Didn’t Disclose Financial Ties
Ashley Yeager | Sep 10, 2018 | 2 min read
José Baselga of Memorial Sloan Kettering took millions of dollars from drug and health care companies but did not report the payments in his research articles.
Concerns over Efficacy and Cost of Muscle Wasting Treatments
Ruth Williams | Nov 11, 2020 | 5 min read
Two new medications for treating a rare and deadly neuromuscular disease have high prices and questionable efficacies, say scientists.
Publishing in English Presents Challenges for International Authors
Jef Akst | Mar 10, 2020 | 8 min read
When submitting manuscripts to Western journals, authors face issues that go beyond language barriers.
How to Successfully Collaborate with Industry
Ashley P. Taylor | Mar 1, 2018 | 8 min read
In efforts to translate basic-science results into pharmaceuticals and other technologies, success cannot be taken for granted.
The Open Data Explosion
Viviane Callier | Jan 1, 2019 | 8 min read
Scientists are working to maximize the benefits and minimize the costs of sharing.
SUCCESS IN TWO CAREERS
Myrna F. Watanabe | Apr 1, 2007 | 4 min read
By Myrna F. WatanabeSUCCESS IN TWO CAREERSCultivating an eye for targets. DANI BOLOGNESI JASON VARNEY | varneyphoto.com By all accounts, Dani Bolognesi has been tremendously successful. His Duke University laboratory did the early work on identifying anti-HIV activity in what would become AZT (zidovudine), the first drug developed against the disease. In March 2003, the Food and Drug Administration approved Fuzeon, an HIV fusion-inhibitor drug that cam
Variation in Cannabis Testing Challenges a Young Industry
Katarina Zimmer | Mar 1, 2020 | 10 min read
The US lacks standardized methods to assess products for potency and safety. That’s a big problem for the labs tasked with doing the testing.

Run a Search

ADVERTISEMENT